All Articles: Announcements
Shultz joins the college with tremendous experience, both at the University of Minnesota and in higher education.
The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.
The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.
Dr. Olihe Okoro is 2022 recipient of the University of Minnesota President's Community-Engaged Scholar Award
Dr. Vicki Ellingrod has been named dean of the University of Michigan College of Pharmacy, effective July 1, 2022. Ellingrod is an alumna of the University of Minnesota College of Pharmacy where she received her bachelor’s degree in pharmacy in 1992 and her Doctor of Pharmacy in 1994.
The Center for Drug Design’s Dr. Swati More and Dr. Robert Vince are recipients of an Innovation Impact Case Award.
Dr. Marilyn Speedie and Dr. Caroline Gaither have been recognized by the American Association of Colleges of Pharmacy.
Dr. Amy L. Pittenger, head of the Department of Pharmaceutical Care & Health Systems and professor, is the recipient of a 2022 Award for Outstanding Contributions to Graduate and Professional Education as part of the 2021-2022 Distinguished Teaching Awards.
Joseph Shultz has accepted the position of acting chief of operations for the University of Minnesota College of Pharmacy, Twin Cities.
Earlier this year, Dr. Olihe Okoro, associate professor in the Department of Pharmacy Practice and Pharmaceutical Sciences was named a 2021-2024 McKnight Presidential Fellow.